These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 38363971

  • 1. Irritable Bowel Syndrome: Effects of a Probiotic Combination in Reducing Stress Response and Symptoms Associated With Irritable Bowel Syndrome.
    Ross SM.
    Holist Nurs Pract; ; 38(2):120-122. PubMed ID: 38363971
    [No Abstract] [Full Text] [Related]

  • 2. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
    Williams EA, Stimpson J, Wang D, Plummer S, Garaiova I, Barker ME, Corfe BM.
    Aliment Pharmacol Ther; 2009 Jan; 29(1):97-103. PubMed ID: 18785988
    [Abstract] [Full Text] [Related]

  • 3. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
    Sadrin S, Sennoune SR, Gout B, Marque S, Moreau J, Grillasca J, Pons O, Maixent JM.
    Cell Mol Biol (Noisy-le-grand); 2017 Sep 30; 63(9):122-131. PubMed ID: 28980935
    [Abstract] [Full Text] [Related]

  • 4. Using metabolomics to decipher probiotic effects in patients with irritable bowel syndrome.
    Madsen K.
    J Clin Gastroenterol; 2011 Sep 30; 45(5):389-90. PubMed ID: 21436725
    [No Abstract] [Full Text] [Related]

  • 5. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):387-94. PubMed ID: 16128676
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial.
    Han K, Wang J, Seo JG, Kim H.
    J Gastroenterol; 2017 Apr 01; 52(4):432-443. PubMed ID: 27178566
    [Abstract] [Full Text] [Related]

  • 7. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 01; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 8. Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome.
    Kajander K, Krogius-Kurikka L, Rinttilä T, Karjalainen H, Palva A, Korpela R.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):463-73. PubMed ID: 17635381
    [Abstract] [Full Text] [Related]

  • 9. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome.
    Pineton de Chambrun G, Neut C, Chau A, Cazaubiel M, Pelerin F, Justen P, Desreumaux P.
    Dig Liver Dis; 2015 Feb 01; 47(2):119-24. PubMed ID: 25488056
    [Abstract] [Full Text] [Related]

  • 10. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome.
    Hong YS, Hong KS, Park MH, Ahn YT, Lee JH, Huh CS, Lee J, Kim IK, Hwang GS, Kim JS.
    J Clin Gastroenterol; 2011 Feb 01; 45(5):415-25. PubMed ID: 21494186
    [Abstract] [Full Text] [Related]

  • 11. [Probiotics as therapeutic agents in irritable bowel syndrome].
    Krammer HJ, Schlieger F, Harder H, Franke A, Singer MV.
    Z Gastroenterol; 2005 May 01; 43(5):467-71. PubMed ID: 15871070
    [Abstract] [Full Text] [Related]

  • 12. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 01; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 13. A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome.
    Kruis W, Chrubasik S, Boehm S, Stange C, Schulze J.
    Int J Colorectal Dis; 2012 Apr 01; 27(4):467-74. PubMed ID: 22130826
    [Abstract] [Full Text] [Related]

  • 14. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):48-57. PubMed ID: 17919270
    [Abstract] [Full Text] [Related]

  • 15. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM, Khosruzzaman SM, Ahmed DS, Sah MP.
    BMC Gastroenterol; 2018 May 25; 18(1):71. PubMed ID: 29801486
    [Abstract] [Full Text] [Related]

  • 16. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Skrzydło-Radomańska B, Prozorow-Król B, Cichoż-Lach H, Majsiak E, Bierła JB, Kanarek E, Sowińska A, Cukrowska B.
    Nutrients; 2021 Feb 26; 13(3):. PubMed ID: 33652763
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
    Sudha MR, Jayanthi N, Aasin M, Dhanashri RD, Anirudh T.
    Benef Microbes; 2018 Jun 15; 9(4):563-572. PubMed ID: 29695183
    [Abstract] [Full Text] [Related]

  • 18. Melatonin regulation as a possible mechanism for probiotic (VSL#3) in irritable bowel syndrome: a randomized double-blinded placebo study.
    Wong RK, Yang C, Song GH, Wong J, Ho KY.
    Dig Dis Sci; 2015 Jan 15; 60(1):186-94. PubMed ID: 25092036
    [Abstract] [Full Text] [Related]

  • 19. A 2-strain mixture of Lactobacillus acidophilus in the treatment of irritable bowel syndrome: A placebo-controlled randomized clinical trial.
    Sadrin S, Sennoune S, Gout B, Marque S, Moreau J, Zinoune K, Grillasca JP, Pons O, Maixent JM.
    Dig Liver Dis; 2020 May 15; 52(5):534-540. PubMed ID: 31952938
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and Safety of New Lactobacilli Probiotics for Unconstipated Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Oh JH, Jang YS, Kang D, Chang DK, Min YW.
    Nutrients; 2019 Nov 27; 11(12):. PubMed ID: 31783597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.